Tags

Type your tag names separated by a space and hit enter

Edaravone administration in pivotal clinical Study 19.

Links

  • Publisher Full Text
  • Authors+Show Affiliations

    ,

    a Department of Neurology, Clinical Research Unit, Montreal Neurological Institute , McGill University , Montreal , QC , Canada.

    b Atrium Health Neurosciences Institute , University of North Carolina School of Medicine , Charlotte , NC , USA.

    Source

    Pub Type(s)

    Journal Article

    Language

    eng

    PubMed ID

    31079469

    Citation

    Genge, Angela, and Benjamin Brooks. "Edaravone Administration in Pivotal Clinical Study 19." Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration, vol. 20, no. 3-4, 2019, pp. 298-299.
    Genge A, Brooks B. Edaravone administration in pivotal clinical Study 19. Amyotroph Lateral Scler Frontotemporal Degener. 2019;20(3-4):298-299.
    Genge, A., & Brooks, B. (2019). Edaravone administration in pivotal clinical Study 19. Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration, 20(3-4), pp. 298-299. doi:10.1080/21678421.2019.1582672.
    Genge A, Brooks B. Edaravone Administration in Pivotal Clinical Study 19. Amyotroph Lateral Scler Frontotemporal Degener. 2019;20(3-4):298-299. PubMed PMID: 31079469.
    * Article titles in AMA citation format should be in sentence-case
    TY - JOUR T1 - Edaravone administration in pivotal clinical Study 19. AU - Genge,Angela, AU - Brooks,Benjamin, Y1 - 2019/05/13/ PY - 2019/5/14/pubmed PY - 2019/5/14/medline PY - 2019/5/14/entrez SP - 298 EP - 299 JF - Amyotrophic lateral sclerosis & frontotemporal degeneration JO - Amyotroph Lateral Scler Frontotemporal Degener VL - 20 IS - 3-4 SN - 2167-9223 UR - https://www.unboundmedicine.com/medline/citation/31079469/Edaravone_administration_in_pivotal_clinical_Study_19 L2 - http://www.tandfonline.com/doi/full/10.1080/21678421.2019.1582672 DB - PRIME DP - Unbound Medicine ER -